Pharma Group Bioeel Sees 1H/2022 Turnover Rise by 21% To over RON312M

10.11.2022 By Laurentiu Cotu

Pharma group Bioeel, owned by businessman Albert Attila, founding member, and Jean Scheftsik de Szolnok, a French citizen, in the first half of this year generated turnover worth RON312 million (EUR63.2 million), up around 21% from the year-earlier period, in line with ZF calculations based on company data.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

 
Keywords:
Bioeel
, earnings
, investment